Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Dev Biol Stand1
Search Results
Sort by
- Bookedited by Chiara Ambrosio, William MacLehose.Contents:
Part 1: Imagining the brain between body and soul. Ventricular localization in late antiquity: the philosophical and theological roots of an enduring model of brain function / Jessica Wright
The pathological and the normal: mapping the brain in medieval medicine / William MacLehose
Imagining the soul: Thomas Willis (1621–1675) on the anatomy of the brain and nerves / Alexander Wragge-Morley
Gaetano Zumbo’s anatomical wax model: from skull to cranium / Rose Marie San Juan
Part 2: Representing the brain and the nervous system: styles, media, practices. The nervous system and the anatomy of expression: Sir Charles Bell’s anatomical watercolours / Brendan Clarke and Chiara Ambrosio
Gertrude Stein’s modernist brain / Chiara Ambrosio
Imagining the brain as a book: Oskar and Cécile Vogt’s "library of brains" / Chantal Marazia and Heiner Fangerau
Pinpricks: Needling, numbness, and temporalities of pain / Lan A. Li
Part 3: Inside the brain: arguments and evidence in the making of the modern neurosciences. From images to physiology: a strange paradox at the origin of modern neuroscience / Paolo Mazzarello
One, no-one and a hundred thousand brains: J.C. Eccles, J.Z. Young and the establishment of the neurosciences (1930s–1960s) / Fabio De Sio
Seeing patterns in neuroimaging data / Jessey Andrew Kenneth Wright.Digital Access ScienceDirect 2018 - ArticlePeter HH, Deutschmann EM, Schultheis W, Deicher H.Dev Biol Stand. 1977 Apr 13-15;38:537-40.23 "high risk" melanoma patients treated with BCG-AIT are compared with a non-randomized control group of 35 Stage II melanoma patients receiving other treatment. The results are discussed. It has been noted that patients with weak initial BCG reactions survived longer than patients with strongly positive first BCG reactions. This observation could be interesting for the choice of immunotherapy.